Strauss Ronald G
University of Iowa DeGowin Blood Center, University of Iowa Hospitals, University of Iowa College of Medicine, Iowa City, IA 52242-1182, USA.
J Clin Apher. 2002;17(3):111-7. doi: 10.1002/jca.10031.
A survey was completed by 25 medical directors at different institutions performing plateletpheresis. The practices of these 25 physicians were analyzed regarding the acceptance/rejection of plateletpheresis donors with a history of cardiac disease/surgery, seizures/epilepsy, cancer, or autoimmune diseases. Although available medical literature documents little risk of these disorders either to donors (i.e., donation reactions) or to transfusion recipients (i.e., disease transmission), up to 24% of medical directors outright reject some of these potential donors while others accept patients/donors with these illnesses, providing they meet certain medical/health criteria. Acceptance/rejection of individuals with medical disorders has relevance for the availability of the blood supply and blood product shortages because several million Americans, diagnosed with these illnesses, represent a sizable pool of potential blood and platelet donors.
一项针对25位在不同机构进行血小板单采术的医学主任的调查已完成。对这25位医生关于接受/拒绝有心脏病/手术史、癫痫发作/癫痫、癌症或自身免疫性疾病史的血小板单采术捐献者的做法进行了分析。尽管现有的医学文献记载这些疾病对捐献者(即捐献反应)或输血接受者(即疾病传播)的风险很小,但高达24%的医学主任会直接拒绝其中一些潜在捐献者,而其他主任则会接受患有这些疾病的患者/捐献者,前提是他们符合某些医学/健康标准。对患有疾病的个体的接受/拒绝与血液供应的可用性和血液制品短缺有关,因为数百万被诊断患有这些疾病的美国人代表了相当大的潜在血液和血小板捐献者群体。